Benzinga | Nov 2, 2021 10:44AM EDT

Nautilus Biotechnology Q3 EPS $(0.12) Misses $(0.10) Estimate

Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.10) by 20 percent.